子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 21 | Substantially colorless halogen-free flame-retardant polyolefin resin composition superior in colorability laminated sheet | JP31522199 | 1999-11-05 | JP3499175B2 | 2004-02-23 | 俊也 狩野 |
| 22 | Modular design and synthesis of amine imide-containing molecules | JP51799595 | 1993-12-28 | JPH09510693A | 1997-10-28 | ケースビア，デイヴィッド; トゥ，チェン; ファース，ポール; シー．ジュニア ホーガン，ジョゼフ |
| (57)【要約】 新規なアミンイミド誘導分子モジュールの設計および合成、ならびに新たな分子および加工材料の構築における該モジュールの使用を開示する。 この新しい分子および加工材料は薬剤の設計および合成に有用な分子認識剤であって、分離および材料科学の分野で利用される。 | ||||||
| 23 | Herbicidal sulphonylaminocarbonyltriazolinone having substituent bonded via oxygen | JP10250992 | 1992-03-30 | JPH05194433A | 1993-08-03 | MUELLER KLAUS-HELMUT; KOENIG KLAUS; KLUTH JOACHIM; LUERSSEN KLAUS; SANTEL HANS-JOACHIM; SCHMIDT ROBERT R |
| PURPOSE: To prepare a new sulphonylaminocarbonyltriazolinone derivative useful as herbicides in treatment before and after germination. CONSTITUTION: The compd. of formula I (R 1 is H, amino, an alkyl, alkenyl, alkinyl, cycloalkyl, aralkyl, aryl, alkylamino, cycloalkylamino or dialkylamino; R 2 is an alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkenyl, aralkyl or aryl; R 3 is an alkyl, aralkyl, aryl or heteroaryl) and the salt thereof, such as 2-(2- methoxycarbonyl-phenyl-sulfonylaminocarbonyl)-4-(methyl-5-phenoxy-2,4-dihydro-3 H-1,2,4-triazol-3-one. The compd. can be obtd., e.g. by reacting the triazolinone of formula II with the sulfonylisocyanate of formula III in the presence of a diluent, if required. COPYRIGHT: (C)1993,JPO | ||||||
| 24 | Method of introducing the azo group | JP27158492 | 1992-10-09 | JP3475434B2 | 2003-12-08 | 義行 宮木; 嘉彦 杉浦 |
| 25 | Substantially colorless halogen free flame retardant polyolefin resin composition and its laminated sheet | JP31522199 | 1999-11-05 | JP2001131353A | 2001-05-15 | KANO TOSHIYA |
| PROBLEM TO BE SOLVED: To provide a halogen free substantially colorless flame retardant polyolefin resin composition having a high practicability capable of replacing a polyvinyl chloride based resin and its laminated sheet, excellent in processability, flexibility, mechanical strength and coloring flexibility. SOLUTION: The substantially colorless resin composition comprises 100 pts.wt of a polyolefin resin, 10-200 pts.wt of a nonhalogen flame retardant and 1-50 pts.wt of a heat decomposable N2 gas generating agent (e.g. an azo compound, a sulfohydrazide compound or a nitroso compound). This invention also includes a film and a laminated sheet obtained by laminating the film to a base cloth comprising a fabric. COPYRIGHT: (C)2001,JPO | ||||||
| 26 | JPS6323824B2 - | JP12616080 | 1980-09-12 | JPS6323824B2 | 1988-05-18 | FURITSUTSU ARUTORUFUA |
| 27 | Method of removing heat of exothermic reaction | JP12616080 | 1980-09-12 | JPS5684626A | 1981-07-10 | FURITSUTSU ARUTORUFUA |
| 28 | 트리아젠 유도체 또는 테트라젠 유도체를 포함하는유기금속증착용 질소원 및 이로부터 형성된 질화막을포함하는 질화물 반도체 소자 | KR1019990049970 | 1999-11-11 | KR1020010046264A | 2001-06-15 | 신종언 |
| PURPOSE: A nitrogen source for depositing an organic metal including a triazene derivative or tetrazene derivative is provided to improve energy efficiency by making nitrogen within a temperature range from 600 to 800 deg.C to form a nitride layer of an excellent crystal at a low temperature. CONSTITUTION: A nitrogen source for depositing an organic metal is composed of a triazene derivative or tetrazene derivative in which at least one hydrogen of triazene or tetrazene is replaced by a dimethylamine radical. A nitride semiconductor device includes a nitride layer formed by receiving nitrogen from the nitrogen source for depositing the organic metal. | ||||||
| 29 | 트리아젠 유도체 또는 테트라젠 유도체를 포함하는유기금속증착용 질소원 및 이로부터 형성된 질화막을포함하는 질화물 반도체 소자 | KR1019990049970 | 1999-11-11 | KR100313907B1 | 2001-11-15 | 신종언 |
| 본발명은트리아젠또는테트라젠의 H가하나이상디메틸아민라디칼로치환되어있는트리아젠유도체또는테트라젠유도체를포함하는유기금속증착용질소원및 이로부터질소를공급받아형성된질화막을포함하는질화물반도체소자에관한것이다. 본발명의질소원은 600 내지 800℃의온도에서 N을유리시킬수 있으므로저온에서좋은결정질의질화물막을제공할수 있다. | ||||||
| 30 | 트리아졸리논 유도체 제조용 중간체 화합물 | KR1019990002314 | 1999-01-25 | KR100243541B1 | 2000-03-15 | 뮐러클라우스헬무트; 쾨니그클라우스; 클루트요아힘; 뤼르쎈클라우스; 잔텔한스-요아힘; 쉬미트로베르트아르. |
| 본 발명은 화학식 9의 화합물 및 그의 제조방법에 관한 것이다:
|
||||||
| 31 | CONTINUOUS FLOW PROCESS FOR THE PRODUCTION OF DIAZO ESTERS | PCT/US2012/028741 | 2012-03-12 | WO2012128985A1 | 2012-09-27 | KRAWCZYK, Marta; KULKARNI, Yashwant |
Processes for producing diazo ester derivatives in a single phase system in a continuous flow reactor. |
||||||
| 32 | A REAGENT, A KIT, AND A METHOD FOR DETECTING AND IDENTIFYING A WIDE RANGE OF ILLICIT DRUGS | PCT/IL2008001149 | 2008-08-21 | WO2009027967A3 | 2010-03-04 | AMISAR SHAI |
| A reagent for detecting and identifying a chemical substance. The reagent is an emulsion including a cobalt salt dissolved in water which also includes at least one organic solvent that is at least partly water-miscible and also including an organic compound which serves as an ion pair color changing indicator or a pH sensitive color changing indicator, the organic compound dissolved in an organic solvent only partly miscible with water. A two product kit for detecting and identifying a chemical substance is also taught. The kit includes the aforementioned reagent and a diazonium salt, typically a diazonium salt having electron withdrawing groups on its phenyl rings. A method for detecting and identifying a chemical substance using the two product kit is also discussed. The reagent, testing kit and method may be used for detecting and identifying controlled substances. | ||||||
| 33 | PREPARATION AND USE OF alpha -KETO PHOSPHONATES | PCT/US0224213 | 2002-07-30 | WO03011221A3 | 2003-07-24 | MCKENNA CHARLES E; KASHEMIROV BORIS A; BONAZ-KRAUSE PATRICIA I |
| Novel phosphonate compounds are provided including a phosphonoglyoxylamide ester, an alpha -keto phosphonophosphinate ester, a carbonylbisphosphonate analog of a nucleotide, and a diazomethylenebisphosphonate analog of a nucleotide, as well as methods of making synthetically and medically useful alpha -keto phosphonate compounds. | ||||||
| 34 | PROCESS FOR SYNTHESIZING ASPARTIC AND GLUTAMIC ACID DERIVATIVES ESPECIALLY USEFUL AS INTERMEDIATES IN THE MANUFACTURE OF A CASPASE INHIBITOR | PCT/US2002/032218 | 2002-10-08 | WO2003042169A2 | 2003-05-22 | MORTIMORE, Michael; PHILPS, Oliver; STUDLEY, John |
The invention relates to novel diazoketone derivatives. The invention also relates to processes for homologation of these diazoketone derivatives. The processes are useful for preparing compounds that are caspase inhibitors. |
||||||
| 35 | IN SITU LANGERHANS CELL VACCINE | PCT/US0207645 | 2002-03-13 | WO02072026A3 | 2003-02-27 | TAKASHIMA AKIRA; KUMAMOTO TADASHI |
| A method for entrapping migratory antigen presenting cells (APCs) and particularly Langerhans cells (LCs,) in vivo provided. The method entails creating an artificial gradient of APC-attracting chemotactic factor in the homing path of APCs in vivo . Also provided is a composition for entrapping APCs and particularly, migratory LCs. In addition, a method for loading APCs in situ with antigen is provided. The method comprises entrapping APCs in vivo and subsequently loading the APCs in situ with antigen. Correspondingly, a composition for loading APCs in situ is also is also provided. Further provided is a method for stimulating the migration of entrapped APCs to draining lymph nodes. The ability to stimulate the migration of entrapped APCs to draining lymph nodes is useful, internalia ) for regulating an immune response in a subject. In addition, an in situ APC-based vaccine is provided which does not require any time-consuming, costly ex vivo manipulations. | ||||||
| 36 | AZOPHENOLS AS ERG ONCOGENE INHIBITORS | PCT/US2016/051098 | 2016-09-09 | WO2017044844A1 | 2017-03-16 | DOBI, Albert L.; DALGARD, Clifton; SRIVASTAVA, Shiv |
Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II), wherein X, X1, X2, X3, X4, X5, R1 through R4 and R9 are as described. An aspect of the present invention relates to a method for treating a disease associated with overexpression of wild type ERG protein, an altered ERG protein, ERG gene transcription or ERG mRNA translation in a subject suffering therefrom, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or Formula (II) |
||||||
| 37 | POLYMER SUPPORTED REAGENTS AND METHODS OF REDUCING AROMATIC NITRO COMPOUNDS BY USING THE SAME | PCT/KR2012001928 | 2012-03-16 | WO2012128515A9 | 2012-12-20 | HAN YANG-KYOO; CHO JIN; LEE SANG-MI; SHIN SEUNG-HOON |
| The present invention relates to a polymer supported reagent comprising a novel crosslinked mesoporous polymer, enabling a simple and easy production of an azoxy compound or an azo compound from an aromatic nitro compound, and a method of selectively reducing an aromatic nitro compound by using the same. The polymer supported reagent comprises a certain acrylamide mesoporous crosslinked polymer. | ||||||
| 38 | STABLE NEUTRAL NITRIC OXIDE SOURCE | PCT/US2008/004904 | 2008-04-16 | WO2008130567A1 | 2008-10-30 | TOONE, Eric, J.; CHAKRAPANI, Harinath |
C-nitroso compound capable of releasing neutral nitric oxide is made stable by forming a Diels Alder adduct thereof which is functionalized at the Diels-Alder double bond to impart the stability. Treatment of the stabilized adduct with agent that removes functionalization and regenerates Diels Alder double bond triggers delivery of neutral nitric oxide via retro Diels-Alder reaction and homolytic scission. |
||||||
| 39 | PEPTIDE DEFORMYLASE INHIBITORS | PCT/US0206275 | 2002-03-01 | WO02070541A3 | 2002-12-19 | XIANG JIA-NING; CHRISTENSEN SIEGFRIED B; LEE JINHWA; MERCER DANIEL J |
| Nobel PDF inhibitors and novel methods for their use are provided. | ||||||
| 40 | PEPTIDE LIGANDS THAT BIND TO SURFACES OF BACTERIAL SPORES | PCT/US1999/000771 | 1999-01-14 | WO99036081A1 | 1999-07-22 | |
| Peptides which bind to surfaces of bacterial spores have been identified by means of biopanning using phage-displayed peptide libraries. The sequences identified thereby are useful for binding studies to determine presence of spores in the environment or clinical setting. | ||||||
QQ群二维码
意见反馈
意见反馈